Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot SMART Design for Pathological Gamblers
This study is currently recruiting participants.
Verified by National Institute on Drug Abuse (NIDA), May 2008
First Received: May 23, 2008   No Changes Posted
Sponsor: National Institute on Drug Abuse (NIDA)
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00685724
  Purpose

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.


Condition Intervention Phase
Pathological Gambling
Behavioral: Motivational Enhancement Therapy (MET)
Behavioral: Cognitive-Behavioral Therapy (CBT)
Phase II

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Factorial Assignment
Official Title: A Pilot SMART Design for Pathological Gamblers

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • self and collateral indices of gambling and gambling related problems [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2008
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.
Behavioral: Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
2: Experimental
Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.
Behavioral: Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
3: Experimental
Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.
Behavioral: Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Behavioral: Cognitive-Behavioral Therapy (CBT)
In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 years old, DSM-IV criteria for pathological gambling
  • >2 gambling episodes in past 60 days
  • spent >$100 wagering in the past 60 days
  • willingness to accept random assignment after the brief intervention.

Exclusion Criteria:

  • Reading level below 5th grade
  • uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00685724

Contacts
Contact: Ellen Ciesielski 860.679.4556 ciesielski@psychiatry.uchc.edu

Locations
United States, Connecticut
University of Connecticut Health Center Recruiting
Farmington, Connecticut, United States, 06030
Principal Investigator: Nancy M Petry, Ph.D.            
Sponsors and Collaborators
Investigators
Principal Investigator: Nancy M Petry, Ph.D. University of Connecticut Health Center
  More Information

No publications provided

Responsible Party: UConn Health Center ( Nancy Petry, Ph.D. )
Study ID Numbers: 07-259, P50-DA09241
Study First Received: May 23, 2008
Last Updated: May 23, 2008
ClinicalTrials.gov Identifier: NCT00685724     History of Changes
Health Authority: United States: Federal Government;   United States: Institutional Review Board

Keywords provided by National Institute on Drug Abuse (NIDA):
pathological gambling
cognitive-behavioral therapy
motivational enhancement therapy

Additional relevant MeSH terms:
Impulse Control Disorders
Gambling
Mental Disorders

ClinicalTrials.gov processed this record on November 27, 2009